224 related articles for article (PubMed ID: 10400728)
1. Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy.
Amado RG; Jamieson BD; Cortado R; Cole SW; Zack JA
J Virol; 1999 Aug; 73(8):6361-9. PubMed ID: 10400728
[TBL] [Abstract][Full Text] [Related]
2. Functional reconstitution of thymopoiesis after human immunodeficiency virus infection.
Kitchen SG; Killian S; Giorgi JV; Zack JA
J Virol; 2000 Mar; 74(6):2943-8. PubMed ID: 10684316
[TBL] [Abstract][Full Text] [Related]
3. Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy.
Withers-Ward ES; Amado RG; Koka PS; Jamieson BD; Kaplan AH; Chen IS; Zack JA
Nat Med; 1997 Oct; 3(10):1102-9. PubMed ID: 9334721
[TBL] [Abstract][Full Text] [Related]
4. Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency.
Rinaldo CR; Huang XL; Fan Z; Margolick JB; Borowski L; Hoji A; Kalinyak C; McMahon DK; Riddler SA; Hildebrand WH; Day RB; Mellors JW
J Virol; 2000 May; 74(9):4127-38. PubMed ID: 10756025
[TBL] [Abstract][Full Text] [Related]
5. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.
Vigano A; Vella S; Saresella M; Vanzulli A; Bricalli D; Di Fabio S; Ferrante P; Andreotti M; Pirillo M; Dally LG; Clerici M; Principi N
AIDS; 2000 Feb; 14(3):251-61. PubMed ID: 10716501
[TBL] [Abstract][Full Text] [Related]
6. Immune restoration by combination of a cytostatic drug (hydroxyurea) and anti-HIV drugs (didanosine and indinavir).
Lori F; Jessen H; Lieberman J; Clerici M; Tinelli C; Lisziewicz J
AIDS Res Hum Retroviruses; 1999 May; 15(7):619-24. PubMed ID: 10331440
[TBL] [Abstract][Full Text] [Related]
7. Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
Landay AL; Bettendorf D; Chan E; Spritzler J; Schmitz JL; Bucy RP; Gonzalez CJ; Schnizlein-Bick CT; Evans T; Squires KE; Phair JP
AIDS Res Hum Retroviruses; 2002 Jan; 18(2):95-102. PubMed ID: 11839142
[TBL] [Abstract][Full Text] [Related]
8. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B
AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207
[TBL] [Abstract][Full Text] [Related]
9. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
Al-Harthi L; Siegel J; Spritzler J; Pottage J; Agnoli M; Landay A
AIDS; 2000 May; 14(7):761-70. PubMed ID: 10839583
[TBL] [Abstract][Full Text] [Related]
10. CD8+ lymphocyte responses to antiretroviral therapy of HIV infection.
Carr A; Emery S; Kelleher A; Law M; Cooper DA
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(4):320-6. PubMed ID: 8948369
[TBL] [Abstract][Full Text] [Related]
11. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).
Hazenberg MD; Stuart JW; Otto SA; Borleffs JC; Boucher CA; de Boer RJ; Miedema F; Hamann D
Blood; 2000 Jan; 95(1):249-55. PubMed ID: 10607709
[TBL] [Abstract][Full Text] [Related]
12. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
Evans TG; Bonnez W; Soucier HR; Fitzgerald T; Gibbons DC; Reichman RC
Antiviral Res; 1998 Oct; 39(3):163-73. PubMed ID: 9833957
[TBL] [Abstract][Full Text] [Related]
13. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
Autran B; Carcelain G; Li TS; Blanc C; Mathez D; Tubiana R; Katlama C; Debré P; Leibowitch J
Science; 1997 Jul; 277(5322):112-6. PubMed ID: 9204894
[TBL] [Abstract][Full Text] [Related]
14. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
Gray CM; Schapiro JM; Winters MA; Merigan TC
AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
[TBL] [Abstract][Full Text] [Related]
15. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.
Kalams SA; Goulder PJ; Shea AK; Jones NG; Trocha AK; Ogg GS; Walker BD
J Virol; 1999 Aug; 73(8):6721-8. PubMed ID: 10400770
[TBL] [Abstract][Full Text] [Related]
16. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of thymic function in HIV-1 patients treated with highly active antiretroviral therapy.
Ye P; Kourtis AP; Kirschner DE
Clin Immunol; 2003 Feb; 106(2):95-105. PubMed ID: 12672400
[TBL] [Abstract][Full Text] [Related]
18. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072
[TBL] [Abstract][Full Text] [Related]
19. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
Zaunders JJ; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright R; Smith D; Grey P; Vizzard J; Carr A; Cooper DA
J Infect Dis; 1999 Aug; 180(2):320-9. PubMed ID: 10395845
[TBL] [Abstract][Full Text] [Related]
20. Thymocyte and thymic microenvironment alterations during a systemic HIV infection in a severe combined immunodeficient mouse model.
Autran B; Guiet P; Raphael M; Grandadam M; Agut H; Candotti D; Grenot P; Puech F; Debre P; Cesbron JY
AIDS; 1996 Jun; 10(7):717-27. PubMed ID: 8805862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
